# Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

> **NCT00834262** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 339 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart 30
- **DRUG:** biphasic insulin aspart 50
- **DRUG:** biphasic insulin aspart 70

## Key facts

- **NCT ID:** NCT00834262
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2016-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00834262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00834262, "Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00834262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*